China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%

MT Newswires Live

2025/03/26

China Resources Pharmaceutical's (HKG:3320) attributable profit fell to 3.35 billion yuan in 2024 from 3.85 billion yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.

Earnings per share at the drug company decreased to 0.53 yuan from 0.61 yuan in the previous year.

Revenue grew to 257.7 billion yuan from 244.7 billion yuan a year earlier.

The company declared a final dividend of 0.052 yuan per share, payable July 14 to shareholders on record as of June 2.

Shares fell 4% during Wednesday's afternoon trading.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2522818042"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522818042\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2522818042?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-26 15:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522818042","market":"nz","top_or_hot":-1,"title":"China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%","media":"MT Newswires Live","content":"<html><body><p> China Resources Pharmaceutical's (HKG:3320) attributable profit fell to 3.35 billion yuan in 2024 from 3.85 billion yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.</p><p>Earnings per share at the drug company decreased to 0.53 yuan from 0.61 yuan in the previous year.</p><p>Revenue grew to 257.7 billion yuan from 244.7 billion yuan a year earlier.</p><p>The company declared a final dividend of 0.052 yuan per share, payable July 14 to shareholders on record as of June 2.</p><p>Shares fell 4% during Wednesday's afternoon trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-26 15:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> China Resources Pharmaceutical's (HKG:3320) attributable profit fell to 3.35 billion yuan in 2024 from 3.85 billion yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.</p><p>Earnings per share at the drug company decreased to 0.53 yuan from 0.61 yuan in the previous year.</p><p>Revenue grew to 257.7 billion yuan from 244.7 billion yuan a year earlier.</p><p>The company declared a final dividend of 0.052 yuan per share, payable July 14 to shareholders on record as of June 2.</p><p>Shares fell 4% during Wednesday's afternoon trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1570","symbol_name":"华润系","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522818042","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522818042","pubTimestamp":1742972851,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Pharmaceutical's  attributable profit fell to 3.35 billion yuan in 2024 from 3.85 billion yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.Earnings per share at the drug company decreased to 0.53 yuan from 0.61 yuan in the previous year.Revenue grew to 257.7 billion yuan from 244.7 billion yuan a year earlier.The company declared a final dividend of 0.052 yuan per share, payable July 14 to shareholders on record as of June 2.Shares fell 4% during Wednesday's afternoon trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1570":"华润系","BK1191":"制药","03320":"华润医药"},"translate_title":"华润医药2024年利润下滑；股价下跌4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":0.9},"content_text":"China Resources Pharmaceutical's (HKG:3320) attributable profit fell to 3.35 billion yuan in 2024 from 3.85 billion yuan in 2023, according to a Wednesday filing with the Hong Kong bourse.Earnings per share at the drug company decreased to 0.53 yuan from 0.61 yuan in the previous year.Revenue grew to 257.7 billion yuan from 244.7 billion yuan a year earlier.The company declared a final dividend of 0.052 yuan per share, payable July 14 to shareholders on record as of June 2.Shares fell 4% during Wednesday's afternoon trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}